RecruitingNot applicableFemale onlyEN originalBreast cancer

Targeted Resection of Axillary Metastatic Lymph Nodes After Breast Cancer Neoadjuvant Chemotherapy

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

This study evaluates the efficacy and feasibility of Carbon Nanoparticle Suspension Injection (CNSI) for Targeted Axillary Dissection (TAD) in breast cancer patients undergoing neoadjuvant chemotherapy (NAC), compared to traditional clip-based methods. By leveraging CNSI's enhanced visibility and stability, the study aims to improve the precision of lymph node removal, reduce surgical complications, and potentially transform clinical practices. Conducted across multiple centers, this randomized controlled trial focuses on clinical outcomes such as lymph node retrieval rates and the accuracy of surgical staging, aiming to establish a safer, more effective approach to managing axillary lymph nodes in breast cancer surgery.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Kobiety w wieku 18-85 lat
  • Potwierdzony histologicznie rak piersi w stadium cT1-4N1-2aM0
  • Ogólny stan zdrowia oceniony na 0 lub 1 w skali ECOG
  • Po chemioterapii przedoperacyjnej: brak przerzutów do węzłów chłonnych w pachwie
  • Napisana zgoda na udział w badaniu

✗ Disqualifies

  • Rak piersi z przerzutami do innych organów (stadium IV)
  • Zapalny rak piersi lub rak obojga piersi
  • Historia operacyjnego leczenia pachwin
  • Warunki medyczne, psychiczne lub społeczne uniemożliwiające uczestnictwo w badaniu
  • Alergia na nanoczęsteczki węgla lub poważne choroby towarzyszące
  • Równoczesny udział w innym badaniu klinicznym

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Maximum age
85 Years
Last updated (source)
February 12, 2025
Sex
Female only

Therapies / drugs in trial

Locations (1)

2nd Affiliated Hospital, School of Medicine, Zhejiang University, China

Hangzhou, China

Trial contact

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.